Skip to main content
Premium Trial:

Request an Annual Quote

Whatman Schleicher & Schuell to Distribute Pepscan Systems Peptide Array

NEW YORK, Jan. 11 (GenomeWeb News) - Whatman Schleicher & Schuell will distribute Pepscan Systems' PepChip kinase substrate array products and services, the companies said today.


Whatman, currently based in Keene, NH, will distribute the peptide arrays in both the US and Europe, a company spokesperson said. Pepscan is based in The Netherlands.


Following its December acquisition of Schleicher & Schuell, Whatman will eventually be relocating its US manufacturing operations to Stanford, Maine, and its US sales and administrative offices to Florham Park, NJ, while maintaining a presence in Europe through Schleicher & Schuell's offices.


The PepChip array is a high-density peptide array that enables screening of kinase activity in complex mixtures, substrate profiling of known and unknown kinases, and specificity testing of kinase inhibitors. The chip allows researchers to profile over 80 percent of the human kinome, the companies said.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.